OICR News / Tag

Ovarian Cancer TRI

TAG ARCHIVE

Browse news tagged Ovarian Cancer TRI.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

TechnologyOvarian cancer

Drug combination results in longer survival for patients with recurrent and advanced ovarian cancer

An OICR-supported research team at the Princess Margaret Cancer Centre has shown that adding a targeted drug to chemotherapy results in longer survival and a stronger response to treatment in a difficult-to-treat form of ovarian…

ArticleFeb 26, 2021

TechnologyOvarian cancer

Evolving treatment to evolving tumours: How OICR-supported researchers are getting ahead of ovarian cancer

OICR-supported Phase II trial uncovers how ovarian cancers become resistant to treatment, identifies new opportunities to personalize treatment for future patients Clinician investigator Dr. Stephanie Lheureux has seen many women fight ovarian cancer – some…

ArticleJul 27, 2020

TechnologyOvarian cancer

Community-driven initiative finds new potential avenue of ovarian cancer treatment

OICR-funded researchers identify promising targets to shut down the spread of ovarian cancer Despite new targeted therapies, ovarian cancers often spread to other organs in the body and become resistant to drugs, leading to nearly…

ArticleJun 11, 2020

TechnologyOvarian cancer

Teaming up to decode DNA damage repair

Ovarian and pancreatic cancer researchers join forces to debunk which treatments work for which patients Ovarian and pancreatic cancer are some of the most challenging cancers to treat but their common characteristics have pointed to…

ArticleMar 24, 2020

TechnologyOvarian cancer

What can we gain from looking at the outliers?: An investigation into long and short-term ovarian cancer survivors

Researchers investigate the clinical, molecular and microenvironment factors that contribute to extreme therapy response and resistance in ovarian cancer patients Some patients with high-grade serous ovarian cancer (HGSOC) respond exceptionally well to therapy, while others…

ArticleDec 13, 2018

TechnologyOvarian cancer

Discovering new ways to deploy the immune system against hidden cancers

Researchers studying ovarian cancer identify adapter protein 3BP2 as a key component of immune system function and a powerful tool that could be used to activate the immune system against hidden tumour cells. A variety…

ArticleNov 06, 2018

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Ovarian Cancer TRI

Discover the latest news and insightsDiscover the latest news and insights

Tagged stories

Drug combination results in longer survival for patients with recurrent and advanced ovarian cancer

Evolving treatment to evolving tumours: How OICR-supported researchers are getting ahead of ovarian cancer

Community-driven initiative finds new potential avenue of ovarian cancer treatment

Cancer solved together — in your inbox

Teaming up to decode DNA damage repair

What can we gain from looking at the outliers?: An investigation into long and short-term ovarian cancer survivors

Discovering new ways to deploy the immune system against hidden cancers